Blurbs

Roth Capital Gets Even More Bullish on Himax Pointing to Stable iPhone Demand for 4Q

Roth Capital analyst Suji Desilva is bumping up the assurance factor when it comes to Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) and its opportunity …

Gilead’s Cell Therapy Opportunity Tempts Maxim to Join the Bullish Camp

Maxim analyst Jason McCarthy has decided the bulls are right when it comes to the meaningful prospects glittering ahead for Gilead Sciences (NASDAQ:GILD) …

Cantor Bets TherapeuticsMD Bears Could Be Getting Desperate; Here’s Why

TherapeuticsMD Inc (NASDAQ:TXMD) has a bull cheering on back of news the drug maker is resubmitting its NDA to the FDA for vaginal …

Wall Street Billionaire Ken Griffin Takes a Chance on Volatile Biotech Players Valeant and Teva

A Wall Street high-roller like Ken Griffin did not make it among the big leagues a.k.

Teva Pharmaceutical Gains New Confidence from Miuzho Amid Restructuring Turnover at Headquarters

After talking with Teva Pharmaceutical (NYSE:TEVA) management, Mizuho analyst Irina Rivkind Koffler is more positive on the rebounding Israeli pharma giant in the …

Marshall Wace Has Bullish Eyes for Two Chinese Tech Players: Momo Inc (MOMO) and Alibaba Group (BABA)

Marshall Wace is a London-based hedge fund firm that has twenty years of experience and many billions of dollars in assets to its …

Roku, Inc. (ROKU) Attracts a Rising Vote of Confidence; Here’s Why

Roku Inc (NASDAQ:ROKU) may be a less risky take on Netflix as a pure-play on the transition of TV viewing from linear TV …

BTIG Cheers as Teva Pharmaceutical Hits Corporate Reset

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has given investors news to stoke some enthusiasm after a long road of debt, exclusivity on multiple …

Here’s Why Digital Power Corporation Shares Blasted Off Today

Digital Power Corporation (NYSE:DPW) is experiencing a through-the-grapevine chain reaction straight out of the page of crypto-currency mania that has seen bitcoin prices …

Teva Pharmaceutical Industries Limited (TEVA) Restructuring Has This Sidelined Analyst Feeling More Positive

New CEO Kare Schultz is steering Teva Pharmaceutical Industries Limited (NYSE:TEVA) back into the good graces of investors, as the recovering Israeli pharma …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts